Recommended for people ages 12 and older with body weight at or above 40 kg, with pulmonary TB caused by organisms that are not known or suspected to be drug-resistant, and who have no contraindications to this regimen. 4-month rifapentine-moxifloxacin TB treatment regimen Intensive Phase Highlights from the 2016 Treatment of Drug-Susceptible Tuberculosis Guidelines.Note: this table is an excerpt from Treatment of Drug-Susceptible Tuberculosis and cites supporting information available in the complete guidelines.
Doses of Antituberculosis Drugs for Adults and Children Treatment of Drug-Susceptible Tuberculosis.6- or 9-month RIPE TB Treatment Regimen.Considerations for Specific People with TB Disease.Frequently Asked Questions (FAQs) on a 4-month rifapentine-moxifloxacin TB treatment regimen.Interim Guidance: 4-Month Rifapentine-Moxifloxacin Regimen for the Treatment of Drug-Susceptible Pulmonary Tuberculosis - United States, 2022.New4-month Rifapentine-moxifloxacin TB Treatment Regimen.TB treatment can take 4, 6, or 9 months depending on the regimen. There are several treatment regimens recommended in the United States for TB disease. Evaluation and Testing Considerations for Drug-susceptible Pulmonary TB Treatment Regimens.Treatment Regimen Considerations for Specific Groups of People with TB Disease.Drug-Susceptible TB Disease Treatment Regimens.
0 kommentar(er)
